Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - TREU JESSE I
Last Updated 
27-Nov-09
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

TREU JESSE I: Declared Holdings
Company/RelationshipReportedShares  Ownership
Cadence Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:CADX
(historical quotes, profile, other insiders)
18-Feb-092,734,040  Indirect
Novacea, Inc.
Beneficial Owner (10% or more)
NasdaqGM:NOVC
(historical quotes, other insiders)
30-Jan-0967,875  Indirect
Orexigen Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:OREX
(historical quotes, profile, other insiders)
24-Nov-092,370,366  Indirect
SenoRx, Inc.
Director
NasdaqGM:SENO
(historical quotes, profile, other insiders)
26-Feb-0821,915  Indirect
Somaxon Pharmaceuticals, Inc.
Director
NasdaqCM:SOMX
(historical quotes, profile, other insiders)
30-Sep-09
8-Jul-09
43,174
   1,302,052
1,345,226
  Direct
  Indirect  
  Total
Volcano Corporation
Beneficial Owner (10% or more)
NasdaqGM:VOLC
(historical quotes, profile, other insiders)
24-Apr-08
16-Jul-08
21,289
   14,782
36,071
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
24-Nov-09 *50,000OREX Purchase at $6.75 per share.
(Cost of $337,500)
23-Nov-09 *150,000OREX Purchase at $6.93 per share.
(Cost of $1,039,500)
20-Nov-09 *250,000OREX Purchase at $6.93 per share.
(Cost of $1,732,500)
12-Nov-09 *62,000OREX Purchase at $6.90 per share.
(Cost of $427,800)
11-Nov-09 *53,600OREX Purchase at $6.93 per share.
(Cost of $371,448)
10-Nov-09 *84,400OREX Purchase at $6.93 per share.
(Cost of $584,892)
30-Sep-09 4,044SOMX Acquisition (Non Open Market) at $0 per share.
18-Aug-09 *13,784OREX Purchase at $7.73 per share.
(Cost of $106,550)
17-Aug-09 *63,201OREX Purchase at $7.64 per share.
(Cost of $482,855)
14-Aug-09 *26,225OREX Purchase at $8 per share.
(Cost of $209,800)
13-Aug-09 *13,000OREX Purchase at $7.85 per share.
(Cost of $102,050)
12-Aug-09 *400,000OREX Purchase at $8 per share.
(Cost of $3,200,000)
11-Aug-09 *104,300OREX Purchase at $7.60 per share.
(Cost of $792,680)
11-Aug-09 *104,300OREX Purchase at $7.60 per share.
(Cost of $792,680)
23-Jul-09 *650,000OREX Purchase at $7.50 per share.
(Cost of $4,875,000)
8-Jul-09 *297,872SOMX Purchase at $1.05 per share.
(Cost of $312,765)
30-Jun-09 9,659SOMX Acquisition (Non Open Market) at $0 per share.
31-Mar-09 28,928SOMX Acquisition (Non Open Market) at $0 per share.
18-Feb-09 *2,780,674CADX Purchase at $7.13 per share.
(Cost of $19,826,205)
30-Jan-09 *150,300NOVC Sale at $0.98 per share.
(Proceeds of $147,294)
29-Jan-09 *63,000NOVC Sale at $0.91 per share.
(Proceeds of $57,330)
28-Jan-09 *36,700NOVC Sale at $0.93 per share.
(Proceeds of $34,131)
31-Dec-08 543SOMX Acquisition (Non Open Market) at $0 per share.
9-Dec-08 *241,890OREX Purchase at $4.93 per share.
(Cost of $1,192,517)
8-Dec-08 *248,411OREX Purchase at $4.47 per share.
(Cost of $1,110,397)
16-Jul-08 *19,357VOLC Sale at $14.49 per share.
(Proceeds of $280,482)
16-Jul-08 *1,130,643VOLC Disposition (Non Open Market)
24-Apr-08 *20,549VOLC Acquisition (Non Open Market)
24-Apr-08 21,289VOLC Acquisition (Non Open Market)
8-Apr-08 *16,832VOLC Sale at $12.98 per share.
(Proceeds of $218,479)
8-Apr-08 *983,168VOLC Disposition (Non Open Market)
26-Feb-08 *2,750SENO Sale at $8.43 per share.
(Proceeds of $23,182)
26-Feb-08 *31,151SENO Acquisition (Non Open Market)
26-Feb-08 *150,000SENO Disposition (Non Open Market)
20-Feb-08 *2,808,988CADX Acquisition (Non Open Market) at $5.34 per share.
(Value of $14,999,995)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?